Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept

被引:32
作者
Rakoczi, Eva [1 ]
Perge, Bianka [2 ]
Vegh, Edit [2 ]
Csomor, Peter [2 ]
Pusztai, Anita [2 ]
Szamosi, Szilvia [2 ]
Bodnar, Nora [2 ]
Szanto, Sandor [2 ]
Szucs, Gabriella [2 ]
Szekanecz, Zoltan [2 ]
机构
[1] Kenezy Gyula Hosp, Inst Clin Pharmacol Infect Dis & Allergol, 2-6 Bartok B St, H-4034 Debrecen, Hungary
[2] Univ Debrecen, Fac Med, Dept Rheumatol, Med & Hlth Sci Ctr, 98 Nagyerdei St, H-4032 Debrecen, Hungary
关键词
Rheumatoid arthritis; Conjugated pneumococcal vaccine; PCV13; Etanercept; Protective antibody level; ANTIBODY-RESPONSE; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; INFLUENZA VACCINATION; ADULTS; IMMUNIZATION; METHOTREXATE; INFECTIONS; RITUXIMAB; DRUGS;
D O I
10.1016/j.jbspin.2015.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To prospectively evaluate the immunogenicity of a 13-valent conjugated pneumococcal vaccine (PCV13) in rheumatoid arthritis (RA) patients undergoing etanercept therapy. Methods: Twenty-two RA patients treated with etanercept (ETA) in combination with methotrexate (MTX) (n=15) or monotherapy (n=7) for at least one year were included. Altogether 24 osteoarthritis patients not receiving biological or MTX therapy, treating only NSAIDs or analgesics served as controls. All subjects were vaccinated with a single dose (0.5 ml) of the PCV13. Pneumococcal antibody levels at baseline, 4 and 8 weeks were assessed by a VaccZyme (TM) Anti-PCP IgG Enzyme Immunoassay Kit. Based on recommendations of the American Academy of Allergy, Asthma & Immunology, an at least two-fold increase in antibody level, as the protective antibody response (pAR) was an indicator of responsiveness (i.e., ratio of postvaccination and prevaccination antibody levels). The antibody levels and their ratios were analysed in a variety of different ways, vaccine safety parameters (fever, infections, changes in regular antirheumatic treatments) were assessed at baseline, 4 and 8 weeks after vaccination. Results: Four weeks after vaccination, the anti-pneumococcal antibody levels significantly increased in both groups. At week 8, antibody levels somewhat decreased in both groups, however, still remained significantly higher compared to baseline. Compared with postvaccination levels at 4 and 8 weeks between two groups, the mean protective antibody levels were higher in control group (1st month P=0.016; 2nd month: P=0.039). Possible predictors of pAR were analysed by logistic regression model. In RA, increases of antibody levels at week 8 compared to baseline exerted a negative correlation with age, (Spearman's R=-0,431; P=0.045). There were no clinically significant side effects or reaction after administration of vaccine observed in any of these patients after the 2-month follow-up period, all patients medical condition were stable. Conclusions: In RA patients treated with ETA, vaccination with PCV13 is effective and safe, resulting in pAR one and two months after vaccination. Higher age at vaccination was identified as predictors of impaired pAR. The efficacy of vaccination may be more pronounced in younger RA patients. The vaccine is safe in RA patients on ETA. (C) 2016 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:675 / 679
页数:5
相关论文
共 26 条
[11]   6 NEWLY RECOGNIZED TYPES OF STREPTOCOCCUS-PNEUMONIAE [J].
HENRICHSEN, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2759-2762
[12]  
Hernández-Cruz B, 1998, J RHEUMATOL, V25, P1900
[13]   Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis [J].
Kapetanovic, MC ;
Saxne, T ;
Sjöholm, A ;
Truedsson, L ;
Jönsson, G ;
Geborek, P .
RHEUMATOLOGY, 2006, 45 (01) :106-111
[14]   Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis [J].
Kapetanovic, Meliha Crnkic ;
Saxne, Tore ;
Jonsson, Goran ;
Truedsson, Lennart ;
Geborek, Pierre .
ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
[15]   Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs [J].
Kapetanovic, Meliha Crnkic ;
Saxne, Tore ;
Truedsson, Lennart ;
Geborek, Pierre .
ARTHRITIS RESEARCH & THERAPY, 2013, 15 (01)
[16]   Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors [J].
Kapetanovic, Meliha Crnkic ;
Roseman, Carmen ;
Jonsson, Goran ;
Truedsson, Lennart ;
Saxne, Tore ;
Geborek, Pierre .
ARTHRITIS AND RHEUMATISM, 2011, 63 (12) :3723-3732
[17]   Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs [J].
Kapetanovic, Meliha Crnkic ;
Roseman, Carmen ;
Jonsson, Goran ;
Truedsson, Lennart .
CLINICAL RHEUMATOLOGY, 2011, 30 (12) :1555-1561
[18]   Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy [J].
Mori, Shunsuke ;
Ueki, Yukitaka ;
Akeda, Yukihiro ;
Hirakata, Naoyuki ;
Oribe, Motohiro ;
Shiohira, Yoshiki ;
Hidaka, Toshihiko ;
Oishi, Kazunori .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (08) :1362-1366
[19]   The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients [J].
Nagel, J. ;
Geborek, P. ;
Saxne, T. ;
Jonsson, G. ;
Englund, M. ;
Petersson, I. F. ;
Nilsson, J-A ;
Kapetanovic, M. C. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2015, 44 (04) :271-279
[20]   The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients [J].
Nagel, Johanna ;
Geborek, Pierre ;
Saxne, Tore ;
Jonsson, Goran ;
Englund, Martin ;
Petersson, Ingemar F. ;
Nilsson, Jan-Ake ;
Truedsson, Lennart ;
Kapetanovic, Meliha C. .
ARTHRITIS RESEARCH & THERAPY, 2015, 17